FUSIONEN VON PRKACB

European patent · EP3221700 · Deleted

Register entry

Publication number
EP3221700
Application number
EP15802296
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 17, 2015
Published
Sep 27, 2017
Granted
Jun 22, 2022
Deleted
Jun 23, 2023
Reason
Annual fee unpaid
IPC classes
G01N 33/574 (2006.01)
Priority
US 201462081445 P 18.11.2014
PCT application
PCT/US2015/061073 17.11.2015
PCT publication
WO2016/081450 26.05.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 23, 2023

    Deleted, fee unpaid

    Published in Swissreg on 23.06.2023

  2. May 3, 2023

    Change

    Published in Swissreg on 03.05.2023

  3. Jun 22, 2022

    Granted

    Published in Swissreg on 22.06.2022

Parties

Holder

Blueprint Medicines Corporation

38 Sidney Street, suite 200, Cambridge, MA 02139, US

Inventor

STRANSKY, Nicolas

Charlestown, MA 02129, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.